Short-term efficacy of tacrolimus ointment and impact on quality of life

Pediatrics International

Volumn 51, Issue 3, 2009, Pages 385-389

  Kondo, Yasuto ^a   Nakajima, Yoichi ^a   Komatsubara, Ryo ^a   Kato, Makiko ^a   Hirata, Noriko ^a   Matuyama, Haruko ^a   Kakami, Michiko ^a   Tsuge, Ikuya ^a   Ohya, Yukihiro ^b   Urisu, Atsuo ^a  

^a FUJITA HEALTH UNIVERSITY   (Japan)

^b NATIONAL CENTER FOR CHILD HEALTH AND DEVELOPMENT   (Japan)

Author keywords

Atopic dermatitis; Children; QOL; Short term; Tacrolimus

Indexed keywords

GLUCOCORTICOID; TACROLIMUS;

ADOLESCENT; ARTICLE; ATOPIC DERMATITIS; CHILD; CLINICAL ARTICLE; CLINICAL TRIAL; DRUG EFFICACY; DRUG WITHDRAWAL; FEMALE; HERPES; HUMAN; INSOMNIA; MALE; OINTMENT; PRESCHOOL CHILD; PRIORITY JOURNAL; PRURITUS; QUALITY OF LIFE; SCHOOL CHILD; SHORT COURSE THERAPY; SKIN BURNING SENSATION; TREATMENT DURATION;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; DERMATITIS, ATOPIC; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; OINTMENTS; QUALITY OF LIFE; TACROLIMUS;

EID: 66549088739     PISSN: 13288067     EISSN: 1442200X     Source Type: Journal    
DOI: 10.1111/j.1442-200X.2008.02741.x     Document Type: Article

References (14)

1. Kay J, Gawkrodger DJ, Mortimer MJ, Jaron AG. The prevalence of childhood atopic eczema in a general population. J. Am. Acad. Dermatol. 1994 30 : 35 9.
2. Leung DY, Bieber T. Atopic dermatitis. Lancet 2003 361 : 151 60.
3. Leo HL, Bender BG, Leung SB, Tran ZV, Leung DY. Effect of pimecrolimus cream 1% on skin condition and sleep disturbance in children with atopic dermatitis. J. Allergy Clin. Immunol. 2004 114 : 691 3.
4. Klein PA, Clark RA. An evidence-based review of the efficacy of antihistamines in relieving pruritus in atopic dermatitis. Arch. Dermatol. 1999 135 : 1522 5.
5. Paller A, Eichenfield LF, Leung DYM et al. A 12-week study of tacrolimus ointment for the treatment of atopic dermatitis in pediatric patients. J. Am. Acad. Dermatol. 2001 44 : S47 57.
6. Rajka G, Langland T. Grading of the severity of atopic dermatitis. Acta Derm. Venereol. Suppl. (Stockh) 1989 144 : 13 14. (Pubitemid 19228703)
7. Otsuki M, Kawashima M, Shibata Y et al. Efficacy and safety of FK506 (tacrolimus) ointment in children with atopic dermatitis: Phase III double-blinded comparison with vehicle ointment. Rinsho Iyaku 2003 19 : 569 95.
8. Lewis-Jones MS, Finlay AY. The children's dermatology life quality index (CDLQ1): Initial validation and practical use. Br. J. Dermatol. 1995 132 : 942 9.
9. Hanifin JM, Paller AS, Eichenfield L et al. Efficacy and safety of tacrolimus ointment treatment for up to 4 years in patients with atopic dermatitis. J. Am. Acad. Dermatol. 2005 53 : s186 94.
10. Wollenberg A, Zoch C, Wetzel S, Plewig G, Przybilla B. Predisposing factors and clinical features of eczema herpeticum: A retrospective analysis of 100 cases. J. Am. Acad. Dermatol. 2003 49 : 198 205. (Pubitemid 36951264)
11. Eichenfield LF, Ho V, Matsunaga J, Leclerc P, Paul C, Hanifin JM. Blood concentrations, tolerability and efficacy of pimecrolimus cream 1% in Japanese infants and children with atopic dermatitis. J. Dermatology 2007 34 : 231 6.
12. Arkwright PD, Gillespie MC, Ewing CI, David TJ. Blinded side-to-side comparison of topical corticosteroid and tacrolimus ointment in children with moderate to severe atopic dermatitis. Clin. Exp. Dermatol. 2006 32 : 145 7.
13. Inagaki N, Shiraishi N, Igeta K et al. Inhibition of scratching behavior associated with allergic dermatitis in mice by tacrolimus, but not by dexamethasone. Eur. J. Pharmacol. 2006 546 : 189 96.
14. Katoh N, Hirano S, Yasuno H, Kishimoto S. Effects of tacrolimus ointment on facial eruption, itch, and scratching in patients with atopic dermatitis. J. Dermatol. 2004 31 : 194 9.